However, previous studies in female patients with Fabry disease have shown a strong correlation between low alpha-galactosidase activity (in association with a highly skewed X inactivation profile) and progression to end-stage renal disease, thereby highly reducing the risk of a false negative in our study population [8,9]. The gene discussed is GLA; the disease is Fabry disease.